Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent Sibaud

Showing results (71-80 of 137) with videos related to

Pageof 14
Sort By:
Bulletin Du Cancer|April 4, 2021
[Management of toxicities of BRAF inhibitors and MEK inhibitors in advanced melanoma]Vincent Sibaud, Lilian Baric, Alain Cantagrel, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 26, 2024
Photoprotection: Current developments and controversiesGiovanni Pellacani, Henry W Lim, Eggert Stockfleth, et al.
Journal of Medical Virology|June 30, 2017
No detection of Merkel cell polyomavirus in oral lichen planus: Results of a preliminary study in a French cohort of patientsMarie Masson Regnault, Emmanuelle Vigarios, Fabrice Projetti, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 3, 2020
Oral mucosal changes induced by adjuvant endocrine therapies in breast cancer patients: clinical aspects and proposal for managementCaroline de Bataille, Marie Castellan, Carole Massabeau, et al.
Oral Oncology|November 14, 2020
Oral acute graft versus host disease after donor lymphocyte infusions: Clinicopathological characterization in a monocenter cohortNuno Gomes, Anne Huynh, Cécile Borel, et al.
Acta Dermato-Venereologica|August 27, 2019
Multiple Keratoacanthoma-like Lesions in a Patient Treated with PembrolizumabMarion Fradet, Vincent Sibaud, Emilie Tournier, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 15, 2024
Expert Opinion on Managing Adverse Reactions Associated With Acalabrutinib Therapy: A Delphi Consensus From FranceLoïc Ysebaert, Stéphane Ederhy, Véronique Leblond, et al.
Archives of Dermatology|June 19, 2008
Sorafenib-induced eruptive melanocytic lesionsHeidi H Kong, Vincent Sibaud, Maria L Chanco Turner, et al.
The Oncologist|October 6, 2020
Dermatologic Adverse Events Associated with Selective Fibroblast Growth Factor Receptor Inhibitors: Overview, Prevention, and Management GuidelinesMario E Lacouture, Vincent Sibaud, Milan J Anadkat, et al.
Melanoma Research|August 28, 2015
Acute skin reaction suggestive of pembrolizumab-induced radiosensitizationVincent Sibaud, Isabelle David, Laurence Lamant, et al.
Pageof 14

Showing results (71-80 of 137) with videos related to

Sort By:
Pageof 14
Bulletin Du Cancer|April 4, 2021
[Management of toxicities of BRAF inhibitors and MEK inhibitors in advanced melanoma]Vincent Sibaud, Lilian Baric, Alain Cantagrel, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 26, 2024
Photoprotection: Current developments and controversiesGiovanni Pellacani, Henry W Lim, Eggert Stockfleth, et al.
Journal of Medical Virology|June 30, 2017
No detection of Merkel cell polyomavirus in oral lichen planus: Results of a preliminary study in a French cohort of patientsMarie Masson Regnault, Emmanuelle Vigarios, Fabrice Projetti, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 3, 2020
Oral mucosal changes induced by adjuvant endocrine therapies in breast cancer patients: clinical aspects and proposal for managementCaroline de Bataille, Marie Castellan, Carole Massabeau, et al.
Oral Oncology|November 14, 2020
Oral acute graft versus host disease after donor lymphocyte infusions: Clinicopathological characterization in a monocenter cohortNuno Gomes, Anne Huynh, Cécile Borel, et al.
Acta Dermato-Venereologica|August 27, 2019
Multiple Keratoacanthoma-like Lesions in a Patient Treated with PembrolizumabMarion Fradet, Vincent Sibaud, Emilie Tournier, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 15, 2024
Expert Opinion on Managing Adverse Reactions Associated With Acalabrutinib Therapy: A Delphi Consensus From FranceLoïc Ysebaert, Stéphane Ederhy, Véronique Leblond, et al.
Archives of Dermatology|June 19, 2008
Sorafenib-induced eruptive melanocytic lesionsHeidi H Kong, Vincent Sibaud, Maria L Chanco Turner, et al.
The Oncologist|October 6, 2020
Dermatologic Adverse Events Associated with Selective Fibroblast Growth Factor Receptor Inhibitors: Overview, Prevention, and Management GuidelinesMario E Lacouture, Vincent Sibaud, Milan J Anadkat, et al.
Melanoma Research|August 28, 2015
Acute skin reaction suggestive of pembrolizumab-induced radiosensitizationVincent Sibaud, Isabelle David, Laurence Lamant, et al.
Pageof 14